Gen-probe, Inc.

Biomerieux Sa

Other

Yeasing Y Yang

Sherrol Hoffa McDonough

Gary G Bee

Steven T Brentano

Thomas B Ryder

Cristina Giachetti

Guy Vernet

Dan Kolk

Nathalie Tran

Odile Babola

Paul Douglas Stull

Marc Spingola

Nick Mark Carter

James John Hogan

Terrie A Burrell

Sherrol H Mcdonough

Garry G Bee

Dan P Kolk

Sequences of nucleic acid oligonucleotides for amplifying different portions of gag and pol genes of HIV-1 and for detecting such amplified nucleic acid sequences are disclosed. Methods of amplifying and detecting HIV-1 nucleic acid in a biological sample using the amplification oligonucleotides specific for gag and pol target sequences are disclosed.

Amplification of HIV-1 sequences for detection of sequences associated with drug-resistance mutations

Nucleic acid sequences and methods for detecting HIV-1 nucleic acid (LTR and pol sequences) in biological samples by detecting amplified nucleic acids are disclosed. Kits comprising nucleic acid oligomers for amplifying HIV-1 nucleic acid present in a biological sample and detecting the amplified nucleic acid are disclosed.

Detection of HIV-1 by nucleic acid amplification

Amplification of HIV-1 gag sequences for detection of sequences associated with drug-resistance mutations

Compositions and methods for synthesizing and detecting HIV-2 specific amplicons. Particularly described are oligonucleotides that are useful as hybridization probes, and amplification primers that facilitate detection of very low levels of HIV-2 nucleic acids.

Kits for detecting HIV-2

Amplification oligonucleotides and hybridization assay probes which distinguish Human Immunodeficiency Virus type 1 from other viruses.

Detection of human immunodeficiency virus type 1

Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations

The present invention discloses hybridization assay probes, amplification primers, nucleic acid compositions and methods useful for detecting Neisseria nucleic acids. Hybridization assay probes and amplification primers that selectively detect and distinguish those from are disclosed. Other hybridization probes selectively detect and not are also described.

Hybridization assay probes and methods for detecting the presence of neisseria meningitiidis subtypes A, C and L in a sample

The present invention discloses hybridization assay probes, amplification primers, nucleic acid compositions and methods useful for detecting Neisseria nucleic acids. Hybridization assay probes and amplification primers that selectively detect Neisseria meningitidis and distinguish those Neisseria meningitidis from Neisseria gonorrohoeae are disclosed. Other hybridization probes selectively detect Neisseria gonorrohoeae and not Neisseria meningitidis are also described.

Nucleic acid probes and amplification oligonucleotides for Neisseria

The present invention discloses hybridization assay probes, amplification primers, nucleic acid compositions and methods useful for detecting Borrelia nucleic acids. Hybridization assay probes and amplification primers that selectively detect Lyme disease-associated Borrelia and distinguish those Borrelia from Borrelia hermsii are disclosed. Other hybridization probes selectively detect Borrelia hermsii and not Lyme disease-associated Borrelia are also described.

Nucleic acid amplification oligonucleotides and probes to Lyme disease

Amplification oligonucleotides and hybridization assay probes which distinguish Human Immunodeficiency Virus type from other viruses.

Growing community of inventors

San Diego, CA, United States of America

Yeasing Y Yang